
TY  - JOUR
TI  - Sleep & Physiology SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_16.x
DO  - doi:10.1111/j.1440-1843.2009.01503_16.x
SP  - A85
EP  - A89
PY  - 2009
ER  - 

TY  - JOUR
TI  - Cell Biology/Immunology SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_4.x
DO  - doi:10.1111/j.1440-1843.2009.01503_4.x
SP  - A46
EP  - A51
PY  - 2009
ER  - 

TY  - JOUR
TI  - Respiratory Nurses SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_15.x
DO  - doi:10.1111/j.1440-1843.2009.01503_15.x
SP  - A84
EP  - A85
PY  - 2009
ER  - 

TY  - JOUR
TI  - Asthma & Allergy SIG 3 – Paediatrics, Epidemiology and Physiology
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_3.x
DO  - doi:10.1111/j.1440-1843.2009.01503_3.x
SP  - A43
EP  - A46
PY  - 2009
ER  - 

TY  - JOUR
TI  - Interventional Pulmonology/Lung Cancer SIGs
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_8.x
DO  - doi:10.1111/j.1440-1843.2009.01503_8.x
SP  - A61
EP  - A64
PY  - 2009
ER  - 

TY  - JOUR
TI  - OELD/Population Health SIGs
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_9.x
DO  - doi:10.1111/j.1440-1843.2009.01503_9.x
SP  - A65
EP  - A67
PY  - 2009
ER  - 

TY  - JOUR
TI  - Asthma & Allergy SIG 2 – Clinical Aspects of Asthma
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_2.x
DO  - doi:10.1111/j.1440-1843.2009.01503_2.x
SP  - A37
EP  - A42
PY  - 2009
ER  - 

TY  - JOUR
TI  - Cystic Fibrosis SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_7.x
DO  - doi:10.1111/j.1440-1843.2009.01503_7.x
SP  - A57
EP  - A60
PY  - 2009
ER  - 

TY  - JOUR
TI  - Oral Presentations
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 41
IS  - S1
SN  - 0141-8955
UR  - https://doi.org/10.1007/s10545-018-0232-x
DO  - doi:10.1007/s10545-018-0232-x
SP  - 1
EP  - 36
PY  - 2018
ER  - 

TY  - JOUR
TI  - Primary Care SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_13.x
DO  - doi:10.1111/j.1440-1843.2009.01503_13.x
SP  - A79
EP  - A80
PY  - 2009
ER  - 

TY  - JOUR
TI  - COPD SIG 2
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_6.x
DO  - doi:10.1111/j.1440-1843.2009.01503_6.x
SP  - A54
EP  - A57
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 19
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.833
DO  - doi:10.1002/ejhf.833
SP  - 5
EP  - 601
PY  - 2017
ER  - 

TY  - JOUR
TI  - ASBMR 22nd annual meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 15
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650150102
DO  - doi:10.1002/jbmr.5650150102
SP  - S1
EP  - S584
PY  - 2000
ER  - 

TY  - JOUR
TI  - Poster Session
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol
VL  - 54
IS  - S2
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.22495
DO  - doi:10.1002/ppul.22495
SP  - S155
EP  - S480
PY  - 2019
ER  - 

TY  - JOUR
TI  - WORLD TRANSPLANT CONGRESS 2006 ORAL ABSTRACTS
JO  - American Journal of Transplantation
VL  - 6
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2006.01446.x
DO  - doi:10.1111/j.1600-6143.2006.01446.x
SP  - 65
EP  - 472
PY  - 2006
ER  - 

TY  - JOUR
TI  - 2016 ASPHO ABSTRACTS
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 63
IS  - S1
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.25998
DO  - doi:10.1002/pbc.25998
SP  - S7
EP  - S103
PY  - 2016
ER  - 

AU  - Eiges, Rachel
AU  - Zak, Naomi
AU  - Reubinoff, Benjamin E.
AU  - Irving, Charles S.
C7  - pp. 447-486
TI  - Embryonic Stem Cells
SN  - 9781119971399
UR  - https://doi.org/10.1002/9781118846193.ch25
DO  - doi:10.1002/9781118846193.ch25
SP  - 447-486
KW  - cell surface markers
KW  - drug discovery
KW  - drug evaluation
KW  - hESC-derived replacement therapy
KW  - human embryonic stem cells
KW  - inner cell mass
KW  - novel drug testing
PY  - 2016
AB  - Summary Human embryonic stem cells (hESCs) hold great promise to provide important new therapeutic approaches in treating age-associated diseases and other medical conditions due to their unique capacity for self-renewal, their pluripotency and their ability to differentiate into a broad variety of cell types. To date, numerous hESC lines have been developed and characterised. We discuss here how hESC lines are derived, their molecular and cellular properties, and how their ability to differentiate into all three embryonic germ layers is determined. We highlight some of the challenges that must be overcome to obtain and evaluate therapeutic populations from hESCs and the strategies that are being developed to enable the use of hESC-derived cell populations in clinical applications. We conclude with a discussion of clinical trials that are beginning to provide evidence for the therapeutic potential of tissue-specific differentiated populations derived from human embryonic stem cells.
ER  - 

TY  - JOUR
TI  - Poster Presentation Abstracts
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 19
IS  - S2
SN  - 9781119971399
UR  - https://doi.org/10.1111/1756-185X.12962
DO  - doi:10.1111/1756-185X.12962
SP  - 21
EP  - 293
PY  - 2016
ER  - 

TY  - JOUR
AU  - Colombo, Graziano
AU  - Clerici, Marco
AU  - Giustarini, Daniela
AU  - Portinaro, Nicola M.
AU  - Aldini, Giancarlo
AU  - Rossi, Ranieri
AU  - Milzani, Aldo
AU  - Dalle-Donne, Isabella
TI  - Pathophysiology of tobacco smoke exposure: Recent insights from comparative and redox proteomics
JO  - Mass Spectrometry Reviews
JA  - Mass Spec Rev
VL  - 33
IS  - 3
SN  - 9781119971399
UR  - https://doi.org/10.1002/mas.21392
DO  - doi:10.1002/mas.21392
SP  - 183
EP  - 218
KW  - tobacco smoke
KW  - inflammation
KW  - (redox) proteomics
KW  - mass spectrometry
KW  - oxidative modifications
KW  - protein oxidation
PY  - 2014
AB  - Abstract First-hand and second-hand tobacco smoke are causally linked to a huge number of deaths and are responsible for a broad spectrum of pathologies such as cancer, cardiovascular, respiratory, and eye diseases as well as adverse effects on female reproductive function. Cigarette smoke is a complex mixture of thousands of different chemical species, which exert their negative effects on macromolecules and biochemical pathways, both directly and indirectly. Many compounds can act as oxidants, pro-inflammatory agents, carcinogens, or a combination of these. The redox behavior of cigarette smoke has many implications for smoke related diseases. Reactive oxygen and nitrogen species (both radicals and non-radicals), reactive carbonyl compounds, and other species may induce oxidative damage in almost all the biological macromolecules, compromising their structure and/or function. Different quantitative and redox proteomic approaches have been applied in vitro and in vivo to evaluate, respectively, changes in protein expression and specific oxidative protein modifications induced by exposure to cigarette smoke and are overviewed in this review. Many gel-based and gel-free proteomic techniques have already been used successfully to obtain clues about smoke effects on different proteins in cell cultures, animal models, and humans. The further implementation with other sensitive screening techniques could be useful to integrate the comprehension of cigarette smoke effects on human health. In particular, the redox proteomic approach may also help identify biomarkers of exposure to tobacco smoke useful for preventing these effects or potentially predictive of the onset and/or progression of smoking-induced diseases as well as potential targets for therapeutic strategies. ? 2013 Wiley Periodicals, Inc. Mass Spec Rev 33: 183?218, 2014.
ER  - 

TY  - JOUR
TI  - Discussed Poster Abstracts
JO  - Fundamental & Clinical Pharmacology
JA  - Fundam Clin Pharmacol
VL  - 32
IS  - S1
SN  - 9781119971399
UR  - https://doi.org/10.1111/fcp.12372
DO  - doi:10.1111/fcp.12372
SP  - 22
EP  - 56
PY  - 2018
ER  - 
